AsiaIPEX is a one-stop-shop for players in the IP industry, facilitating IP trade and connection to the IP world. Whether you are a patent owner interested in selling your IP, or a manufacturer looking to buy technologies to upgrade your operation, you will find the portal a useful resource.

Back to search results

Glyburide as a Treatment for Anxiety

Detailed Technology Description: Dr. Freund from the University of Illinois is developing a method of treating anxiety with the diabetes drug, glyburide.

Countries: Not Available

Application No.: None

*Abstract: Dr. Freund from the University of Illinois is developing a method of treating anxiety with the diabetes drug, glyburide. By exploring the effects of anxiogenics like adenosine on the brain, Dr. Freund is developing the treatment of anxiety through use of ATP-sensivitive potassium channel blockers. Though there are many anxiety medications currently available, these drugs have various side effects. Additionally, current medications are not effective on all individuals, but the number of people using anti-anxiety medication is increasing.
For more information about this technology, please contact the University of Illinois at Urbana-Champaign Office of Technology Management at otm@illinois.edu.

*IP Issue Date: None

*IP Type: Other Patent

Country/Region: USA

For more information, please click Here